Melissa B. Epperly

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: Nautilus Biotechnology Inc., 3 years.

3 years · Since 2023
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 23, 2026 Roivant Sciences Ltd. Grant or award +513 — —
Oct 23, 2026 Roivant Sciences Ltd. Shares withheld for tax −116 $36.49 $4,233
Oct 1, 2026 Roivant Sciences Ltd. Option exercise +17,750 $4.46 $79,165
Oct 1, 2026 Roivant Sciences Ltd. Open-market sale −16,850 $36.08 $607,948
Oct 1, 2026 Roivant Sciences Ltd. Open-market sale −900 $36.57 $32,913
Sep 16, 2026 Roivant Sciences Ltd. Grant or award +5,054 — —
Sep 15, 2026 Roivant Sciences Ltd. Open-market sale −4,338 $39.65 $172,002
Sep 15, 2026 Roivant Sciences Ltd. Open-market sale −600 $40.38 $24,228
Sep 10, 2026 Roivant Sciences Ltd. Shares withheld for tax −2,179 $40.94 $89,208
Jul 17, 2026 Roivant Sciences Ltd. Grant or award +543 — —
Jun 29, 2026 Roivant Sciences Ltd. Option exercise +17,750 $4.46 $79,165
Jun 29, 2026 Roivant Sciences Ltd. Open-market sale −15,002 $34.32 $514,869
Jun 29, 2026 Roivant Sciences Ltd. Open-market sale −2,748 $34.71 $95,383
Apr 17, 2026 Roivant Sciences Ltd. Grant or award +670 — —
Mar 16, 2026 Roivant Sciences Ltd. Open-market sale −41,861 $28.68 $1,200,573

Questions about Melissa B. Epperly

What boards is Melissa B. Epperly on?

Melissa B. Epperly sits on the boards of Nautilus Biotechnology Inc. and Roivant Sciences Ltd.

How long has Melissa B. Epperly served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.